Medication info
Telmisartan/Amlodipine/Chlorthalidone Tablets 40/2.5/12.5 mg (Telmisartan, Amlodipine Besylate Hydrate, Chlorthalidone)

Telmisartan/Amlodipine/Chlorthalidone Tablets 40/2.5/12.5 mg (Telmisartan, Amlodipine Besylate Hydrate, Chlorthalidone)

Prescription medicationTablet경구
Ingredient · strength
Telmisartan›40mg / 1 tabletS-Amlodipine Besylate Dihydrate›3.69mg / 1 tabletChlorthalidone›12.5mg / 1 tablet
Manufacturer / importer
(주)종근당
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202502826 · Approved 2025.10.31

Summary

Main use
Improvement in blood pressure control for essential hypertension
Who takes it
Adults
Adult dose
This medication should be taken once daily, 1 tablet with water, regardless of meals. It is recommended to take it at the same time every day (e.g., morning). For patients whose blood pressure is not controlled with Telmisartan/Amlodipine (Amlodipine) combination therapy, this medication 40/2.5/12.5 mg can be prescribed, and the dosage should be adjusted with intervals of more than 2 weeks considering the patient's blood pressure response. The maximum dose of this medication

Ingredients

Manufacturer
(주)종근당

Efficacy & effects

Improvement in blood pressure control for essential hypertension

  • Essential hypertension
View approved original text

This medication is used in combination therapy with Telmisartan and Amlodipine (Amlodipine) to appropriately control blood pressure in patients with essential hypertension. These two drugs work together to dilate blood vessels and lower blood pressure, thereby reducing the burden on the heart and blood vessels. It helps to reduce the risk of complications caused by high blood pressure. Therefore, it is effectively used for the treatment of essential hypertension, contributing to a stable maintenance of the patient's blood pressure.

How to take

Adult dose

This medication should be taken once daily, 1 tablet with water, regardless of meals. It is recommended to take it at the same time every day (e.g., morning). For patients whose blood pressure is not controlled with Telmisartan/Amlodipine (Amlodipine) combination therapy, this medication 40/2.5/12.5 mg can be prescribed, and the dosage should be adjusted with intervals of more than 2 weeks considering the patient's blood pressure response. The maximum dose of this medication

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. Patients with impaired liver function or progressive liver disease should be cautious, as this medication may pose a risk of hepatic coma. Patients with severe kidney disease may experience elevated nitrogen levels in the blood and potential drug accumulation, so caution is necessary. Patients with allergies or hypersensitivity to the ingredients of this medication, pregnant or breastfeeding women, and those with severe liver impairment should not take this medication. Patients with heart valve diseases, severe hypotension, renal failure, or those taking specific medications should also be cautious when using this product. This medication may cause various side effects such as dizziness, hypotension, headache, abdominal pain, rash, etc., and should consult a doctor immediately if unusual symptoms occur. Due to the risk of low blood pressure or electrolyte imbalance, regular monitoring of blood pressure and blood tests is necessary. Caution is needed when driving or operating hazardous machinery as dizziness or drowsiness may occur. Older adults should use this medication cautiously and adjust the dosage, as hyponatremia or hypokalemia may frequently occur during treatment.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, cough with fever accompanying respiratory difficulties, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and very severe headaches, thunderclap headaches, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

  • Dizziness
  • dyslipidemia
  • lumbago
  • rash
  • abdominal pain
  • rectal bleeding
  • nausea
  • hemorrhagic gastritis
  • constipation
  • retinal hemorrhage
Show 23 more
  • visual disturbances
  • chest discomfort
  • chest pain
  • lethargy
  • hypokalemia
  • hyponatremia
  • gingivitis
  • gastrointestinal submucosal tumors
  • insomnia
  • rash
  • hypotension
  • foreign body sensation
  • musculoskeletal stiffness
  • headache
  • decreased sensitivity
  • loss of appetite
  • mild gastrointestinal discomfort
  • mild nausea and vomiting
  • stomach pain
  • diarrhea
  • anxiety
  • depression
  • nervousness.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. Maintaining appropriate temperature and container conditions can ensure the medication's effectiveness is retained for a long time.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.